Literature DB >> 11211244

Urinary cotinine levels of smokeless tobacco (Maraş powder) users.

I Cok1, R Oztürk.   

Abstract

Smokeless tobacco is used in various forms in some countries of the world. "Maraş otu" is a kind of smokeless tobacco usage in the Southeastern region of Turkey. The use of smokeless tobacco causes nicotine addiction and dependence. Moreover this type of smokeless tobacco usage is one of the risk factors for oral cancers and genotoxic damages for users. Cotinine is widely used as a biomarker of tobacco consumption and intake of nicotine. Therefore, urine samples were collected from people who are using Maraş powder and smoking cigarettes, and passive smokers, and the levels of cotinine investigated. The purpose of this study is to determine the cotinine levels of Maraş powder users and to compare the results with cigarette smokers and passive smokers. Urinary cotinine levels of subjects were determined by using capillary gas chromatography with FID detection. The mean (+/- SD) urinary cotinines have been determined as 6467.35+/-3198 microg/g creatinine for 26 Maraş powder users, 1943.92+/-1443 microg/g creatinine for 26 cigarette smokers and 198.62+/-420.82 microg/g creatinine for 26 passive smokers. A significant difference has been found between cotinine levels of Maraş powder users and cigarette smokers, which is three times higher in Maraş powder users (p<0.001). The present study suggests that smokeless tobacco poses a threat to public health and it should not be viewed as a safe alternative to cigarettes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11211244     DOI: 10.1191/096032700670928812

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  5 in total

1.  "Maras Powder" a Form of Smokeless Tobacco as a Perioperative Risk Factor in Microsurgery.

Authors:  Tahsin Oğuz Acartürk
Journal:  J Hand Microsurg       Date:  2014-03-09

2.  Comparison of effects of smoking and smokeless tobacco "Maras powder" use on humoral immune system parameters.

Authors:  Murat Aral; Hasan Cetin Ekerbicer; Mustafa Celik; Pinar Ciragil; Mustafa Gul
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

3.  Effects of smokeless tobacco "Maras powder" use on nitric oxide and cardiovascular risk parameters.

Authors:  Aytekin Guven; Fatma Tolun
Journal:  Int J Med Sci       Date:  2012-10-25       Impact factor: 3.738

4.  Evaluation of left atrial mechanical function and atrial conduction abnormalities in Maras powder (smokeless tobacco) users and smokers.

Authors:  Ahmet Akcay; M Naci Aydin; Gurkan Acar; Bulent Mese; Mustafa Çetin; Mehmet Akgungor; Eren Cabioglu; Orhan Bozoglan; Idris Ardic; Musa Çakici
Journal:  Cardiovasc J Afr       Date:  2015 May-Jun       Impact factor: 1.167

5.  Otorhinolaryngological symptoms among smokeless tobacco (Maras powder) users.

Authors:  Saime Sagiroglu; Aysegul Erdogan; Adem Doganer; Ramazan Azim Okyay
Journal:  North Clin Istanb       Date:  2018-08-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.